ST 00937
Alternative Names: ST-00937Latest Information Update: 03 May 2024
At a glance
- Originator Seed Therapeutics
- Class Anti-infectives; Antineoplastics
- Mechanism of Action Proteolysis
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer; CNS disorders; Infections